NIH-funded research R21 grant

Creating a new type of HIV for studying AIDS

Official title: Engineering simian-compatible HIV-1

Funded at University of North Texas Hlth Sci Ctr · NIH-11009371 · Data updated 2026-11-12

This study is looking at a specially modified version of the HIV virus to help researchers learn how it affects the immune system, which could lead to better treatments and vaccines for people living with HIV/AIDS.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of North Texas Hlth Sci Ctr
NIH-funded
Lab location1 site (Fort Worth, United States)
Project startAugust 21, 2024
Project endJune 30, 2026
Funding year2024
Award (this year)$183,602
NIH project number1R21AI179337-01A1
Project IDNIH-11009371 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation or benefit from this research would be individuals affected by HIV/AIDS or those at high risk of infection.

Less likely to help

Patients who are not affected by HIV/AIDS or do not have risk factors for the virus may not receive any benefit from this research.

What this research studies

This research focuses on engineering a modified version of the HIV virus that is compatible with simian models to better understand AIDS pathogenesis. By constructing a chimeric HIV-1 backbone with minimal SIV gene fragments, the study aims to investigate how this modified virus can activate resting T cells, which is crucial for understanding HIV replication and developing effective vaccines and therapies. Patients may benefit from insights gained through this research, which could lead to improved treatments for HIV/AIDS. The methodology involves using human peripheral blood mononuclear cells to test the activation of T cells by the engineered virus.

Why it matters

Potential benefit: If successful, this research could lead to breakthroughs in understanding and treating HIV/AIDS.

How similar studies have gone: Previous research with similar approaches has shown promise, particularly in the use of chimeric viruses for studying HIV dynamics.

Where this research is happening

  • University of North Texas Hlth Sci Ctr
    Fort Worth, United States
    Active

Researchers

  • Principal investigator: Park, in-Woo — University of North Texas Hlth Sci Ctr
  • Study coordinator: Park, in-Woo

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.